Taysha Gene Therapies (TSHA) Shares Outstanding (Entity) (2019 - 2026)
Taysha Gene Therapies (TSHA) posted Shares Outstanding (Entity) of 325.3 million for Q2 2026, up 19.3% from 272.73 million a year earlier but down 11.3% from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
For FY2025, Taysha Gene Therapies' Shares Outstanding (Entity) came in at 285.05 million, up 39.1% from FY2024.
- Annual Shares Outstanding (Entity) has increased for six consecutive years, with a five-year compound annual growth rate of 74.4% (FY2020 to FY2025).
- In prior years, Taysha Gene Therapies' Shares Outstanding (Entity) was 204.94 million in FY2024 (+76.5%), 116.12 million in FY2023 (+164.2%), 43.95 million in FY2022 (+14.2%) and 38.47 million in FY2021 (+117.8%).
- Quarterly Shares Outstanding (Entity) has run from a low of 38.47 million in Q3 2021 to a high of 366.63 million in Q1 2026 over five years.
- On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last 23 quarters, with growth averaging 49.4% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 1.9% in Q1 2022 to 227.9% in Q3 2021.
- According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 366.63 million (Q1 2026), 285.05 million (Q4 2025) and 353.31 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Taysha Gene Therapies | 1.58 Bn | 1.58 Bn | - | 325.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 325.30 Mn |
| Mar 31, 2026 | 366.63 Mn |
| Dec 31, 2025 | 285.05 Mn |
| Sep 30, 2025 | 353.31 Mn |
| Jun 30, 2025 | 272.73 Mn |
| Mar 31, 2025 | 269.31 Mn |
| Dec 31, 2024 | 204.94 Mn |
| Sep 30, 2024 | 267.82 Mn |
| Jun 30, 2024 | 201.38 Mn |
| Mar 31, 2024 | 187.02 Mn |
| Dec 31, 2023 | 116.12 Mn |
| Sep 30, 2023 | 125.70 Mn |
| Jun 30, 2023 | 64.43 Mn |
| Mar 31, 2023 | 63.47 Mn |
| Dec 31, 2022 | 43.95 Mn |
| Sep 30, 2022 | 41.18 Mn |
| Jun 30, 2022 | 41.02 Mn |
| Mar 31, 2022 | 38.47 Mn |
| Dec 31, 2021 | 38.47 Mn |
| Sep 30, 2021 | 38.47 Mn |
API Access
Taysha Gene Therapies Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();